Key result
Fetal echocardiography serves as the definitive modality for diagnosing fetal congenital heart disease, with referrals guided by specific maternal, fetal, and familial risk factors.
Fetal echocardiography is the definitive modality for diagnosing fetal congenital heart disease, and its use is guided by specific fetal, maternal, and familial risk factors.
Answers are grounded in this paper and cite their sources.
Supports risk-stratified fetal echocardiography referrals in practice; leaves open need for prospective validation of evolving indications.
Fetal echocardiography is presently the definitive modality for diagnosing and evaluating fetal congenital heart disease (CHD). Fetal heart disease frequently occurs sporadically without a known risk factor; however, certain pregnancies carry a higher risk of the fetus having CHD. Various known factors place the pregnancy and fetus in a high-risk category. To understand "who needs a fetal echocardiogram," one must recognize and identify the risk factors. Referral indications for a fetal echocardiogram are based on these risk factors that include fetal chromosomal anomalies, fetal extracardiac defects, fetal arrhythmias, maternal teratogenic exposures, maternal metabolic risks, and various inherited syndromes. Referral indications are reviewed along with the associated risk of the fetus having a congenital cardiac abnormality. The anticipated cardiac defect based on the specific referral reason along with the associated frequency of CHD is also addressed. Reasons for performing a fetal echocardiogram, various modalities of imaging, and the benefits and limitations of a study are included. The question of who needs a fetal echocardiogram is closely enmeshed with recognition of the fetal, maternal, and familial risk factors.
No takes yet. Share an insight, caveat, or question.
Nancy A. Ayres (1998) conducted a review in Fetal congenital heart disease (CHD). Fetal echocardiography was evaluated. Fetal echocardiography serves as the definitive modality for diagnosing fetal congenital heart disease, with referrals guided by specific maternal, fetal, and familial risk factors.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: